Short sellers stepped up pressure this week across several US-listed names. Chewy leads the most notable movers. Its short interest hit 57.9% of free float — up 6.5 percentage points in just seven days. That is one of the biggest jumps among mid-cap names.
Dave Inc. saw an even sharper move. SI jumped 13.7 points to 30.4% of free float. The fintech lender is now one of the most heavily shorted names in its peer group.
Grindr had the most dramatic swing. Its SI leapt from 1.4% to 12.4% in a week — a more than 9x increase. That kind of move signals fresh bearish positioning, not a gradual build.
Tempus AI climbed to 30.8% SI. Bears are tight on borrow — availability sits at just 39% of short interest. That creates squeeze risk if sentiment shifts.
On the unwind side, Shake Shack saw SI drop 5 points to 12.8%. The Gap shed 4.6 points to 12.2%. Both names saw bears step back.
Gene-editing stocks remain heavily shorted. Intellia Therapeutics sits at 38.4% and Beam Therapeutics at 30%. Both rose week-on-week, keeping the biotech sector firmly in bearish crosshairs.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
